PBE Holdings Information

PBE is an equity ETF with a total of 33 individual holdings. The top holdings are Vertex Pharmaceuticals stock at 5.04%, Amgen at 4.84%, Biogen at 4.78%, Royalty Pharma at 4.66%, and Alnylam Pharmaceuticals at 4.60%.

Total Holdings

Top 10 Percentage

43.58%

Asset Class

Equity

ETF Category

Health

Assets

257.89M

PE Ratio

20.68

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	VRTX	Vertex Pharmaceuticals Incorporated	5.04%	28,896
2	AMGN	Amgen Inc.	4.84%	37,497
3	BIIB	Biogen Inc.	4.78%	65,241
4	RPRX	Royalty Pharma plc	4.66%	233,880
5	ALNY	Alnylam Pharmaceuticals, Inc.	4.60%	42,629
6	REGN	Regeneron Pharmaceuticals, Inc.	4.54%	19,849
7	UTHR	United Therapeutics Corporation	4.39%	21,777
8	GILD	Gilead Sciences, Inc.	4.33%	94,196
9	VCYT	Veracyte, Inc.	3.24%	155,417
10	CDNA	CareDx, Inc.	3.18%	318,987
11	PTCT	PTC Therapeutics, Inc.	3.15%	101,567
12	TECH	Bio-Techne Corporation	3.09%	143,235
13	PTGX	Protagonist Therapeutics, Inc.	3.08%	68,723
14	ILMN	Illumina, Inc.	3.04%	47,313
15	RGEN	Repligen Corporation	3.03%	59,649
16	VCEL	Vericel Corporation	3.01%	196,482
17	BCRX	BioCryst Pharmaceuticals, Inc.	2.98%	811,213
18	INCY	Incyte Corporation	2.82%	70,762
19	ACAD	ACADIA Pharmaceuticals Inc.	2.77%	323,188
20	QGEN	Qiagen N.V.	2.75%	193,331
21	BMRN	BioMarin Pharmaceutical Inc.	2.73%	129,935
22	NBIX	Neurocrine Biosciences, Inc.	2.69%	44,121
23	EXEL	Exelixis, Inc.	2.67%	137,474
24	COLL	Collegium Pharmaceutical, Inc.	2.66%	203,404
25	HALO	Halozyme Therapeutics, Inc.	2.61%	99,985

Showing 25 of 33 holdings

Subscribe to see the full list

Activate Now

As of Jun 24, 2026